EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Cost of Revenue (2019 - 2026)

EyePoint (EYPT) posted Cost of Revenue of $528000.0 for Q1 2026, up 40.8% sequentially from $375000.0 in Q4 2025, and down 34.41% YoY from $805000.0 in Q1 2025.

Analysis

EyePoint (EYPT) Cost of Revenue (2019 - 2026) Analysis & Trends

EyePoint has reported Cost of Revenue for 8 years, with the latest figure at $528000.0 in Q1 2026.

  • Quarterly Cost of Revenue fell 34.41% year-over-year to $528000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 52.39% YoY) and the FY2025 annual result came in at $2.1 million, down 44.34% from the prior year.
  • Cost of Revenue rose to $528000.0 in Q1 2026 per EYPT's latest filing, from $375000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $3.4 million in Q4 2022 and troughed at $165000.0 in Q2 2025.
  • A 5-year average of $1.1 million and a median of $816000.0 in 2024 frame the typical range for Cost of Revenue.
  • The sharpest annual moves came in 2022 and 2025: Cost of Revenue climbed 27.84% in 2022, then plunged 88.22% in 2025.
  • Over 5 years, Cost of Revenue stood at $3.4 million in 2022, then tumbled by 70.73% to $998000.0 in 2023, then dropped by 18.24% to $816000.0 in 2024, then tumbled by 54.04% to $375000.0 in 2025, then surged by 40.8% to $528000.0 in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $528000.0, $375000.0, and $721000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 145.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 67.21 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 528,000.00
Dec 31, 2025 375,000.00
Sep 30, 2025 721,000.00
Jun 30, 2025 165,000.00
Mar 31, 2025 805,000.00
Dec 31, 2024 816,000.00
Sep 30, 2024 736,000.00
Jun 30, 2024 1.40 Mn
Mar 31, 2024 759,000.00
Dec 31, 2023 998,000.00
Sep 30, 2023 1.20 Mn
Jun 30, 2023 1.79 Mn
Mar 31, 2023 640,000.00
Dec 31, 2022 3.41 Mn
Sep 30, 2022 1.41 Mn
Jun 30, 2022 1.73 Mn
Mar 31, 2022 1.78 Mn
Dec 31, 2021 3.03 Mn
Sep 30, 2021 1.83 Mn
Jun 30, 2021 1.93 Mn